Jack Keating Joins Implant Sciences’ Board of Directors

WILMINGTON, Mass.–Implant Sciences Corporation (OTCBB: IMSC – News), a supplier of systems and sensors for the homeland security market and related industries, today announced the addition of Jack Keating to the Company’s Board of Directors.

Glenn D. Bolduc, Implant Sciences’ Chief Executive Officer, commented, “Jack Keating’s vast experience in global supply chain operations and in all matters concerning shipping and transportation will be a valuable asset to our Company as we continue our growth in the transportation security sector. We are delighted to have him join our Board of Directors.”

Mr. Keating commented, “Implant Sciences has an opportunity to use their proprietary technology to allow global shippers to improve their ability to safely move cargo around the globe. I am excited to be on the Board and help this Company realize their potential in this important field.”

Mr. Keating, 55, is Vice President of Global Customer Fulfillment for the Timberland Company, a premium global brand with sales of more than $1.2 billion in 2008. Mr. Keating has worked for Timberland for 17 years, and is currently responsible for all of Timberland’s transportation, distribution, customs and order management. In addition, Mr. Keating oversees Timberland’s North American customer service and apparel sourcing operations. Mr. Keating has more than 30 years of experience in the shipping and transportation industry, and is a respected expert in retail distribution and transportation. Mr. Keating holds a B.A. from Bridgewater State University and an M.B.A. from Suffolk University.

About Implant Sciences

Implant Sciences develops, manufactures and sells sophisticated sensors and systems for the Security, Safety and Defense (SS&D) industries. The Company has developed proprietary technologies used in its commercial explosive trace detection systems which ship to a growing number of locations domestically and internationally. For further details on the Company and its products, please visit the Company’s website at www.implantsciences.com.

Safe Harbor Statement

This press release may contain certain “forward-looking statements,” as that term is defined in the Private Securities Litigation Reform Act of 1995. Such statements are based on management’s current expectations and are subject to risks and uncertainties that could cause the Company’s actual results to differ materially from the forward-looking statements. Such risks and uncertainties include, but are not limited to, the risks that: because the NYSE Amex has delisted our common stock, it may be extremely difficult to raise capital; if third party credit is unavailable, our working capital could be restricted and we may not be able to borrow capital; and other risks and uncertainties described in the Company’s filings with the Securities and Exchange Commission, including its most recent Forms 10-K, 10-Q and 8-K. Such statements are based on management’s current expectations and assumptions which could differ materially from the forward-looking statements.

< | >